Accenture leans into regulated AI

Accenture is putting more money into “regulated AI” as its stock trades near a 52-week low. (newsroom.accenture.com) (google.com) On April 23, Accenture said its venture arm invested in Iridius, a startup that builds AI systems with compliance checks and audit trails for regulated industries including life sciences and pharmaceuticals. Accenture said the companies will partner to help clients scale AI while keeping traceability and regulatory controls built into the software. (newsroom.accenture.com) The same day, Accenture joined CrowdStrike’s Project QuiltWorks, a coalition with EY, IBM Cybersecurity Services, Kroll and OpenAI aimed at finding and fixing software flaws that frontier AI models are surfacing in production code. CrowdStrike said the effort uses models from OpenAI and Anthropic to assess and prioritize those vulnerabilities. (markets.ft.com) (news.bloomberglaw.com) Regulated AI is software designed for sectors where companies must prove what a system did, why it did it, and who approved it. In drug development and other life-sciences work, that means keeping records that can stand up to internal audits and outside regulators. (newsroom.accenture.com) (natlawreview.com) That focus has become more urgent as companies move from AI pilots to wider deployments inside legal, health, finance and security workflows. Accenture said its Iridius partnership is meant to help clients move beyond isolated pilots and into enterprise-wide use with compliance and auditability built in. (natlawreview.com) The push comes as investors question Accenture’s growth story. Accenture reported second-quarter fiscal 2026 revenue of $18.0 billion and record new bookings of $22.1 billion on March 19, while raising its full-year local-currency revenue growth outlook to 3% to 5%. (newsroom.accenture.com) (businesswire.com) Even after that report, Accenture shares closed at $178.28 on April 24 after touching a 52-week low area around $177, according to Google Finance data. Investing.com said the stock hit $177.37, and the shares were down roughly 39% over the prior 12 months. (google.com) (in.investing.com) Iridius is a small bet compared with Accenture’s overall balance sheet, but it fits the company’s recent pattern of backing tools that make enterprise AI easier to govern. CrowdStrike’s coalition points to the same problem from the security side: AI can speed coding and also expose more weaknesses for companies to clean up. (newsroom.accenture.com) (markets.ft.com) For Accenture, that leaves two numbers moving in opposite directions: AI partnerships are expanding, while the share price is still falling. The company is betting that compliance and security work will turn AI demand into steadier revenue before investors lose patience. (newsroom.accenture.com) (google.com)